The NYU Cancer Institute Joins OncLive's Strategic Alliance Partnership

PLAINSBORO, N.J. —OCTOBER 11, 2013 –OncLive^® is pleased to announce that the NYU Cancer Institute has joined its Strategic Alliance Partnership program.

By joining the growing number of top cancer clinics and institutions that participate in the Strategic Alliance Partnership program, the NYU Cancer Institute will be able to work with OncLive to promote its patient care, research, education, and community outreach initiatives to a national audience of oncology professionals.

The NYU Cancer Institute is an NCI-designated cancer center that offers state-of-the-art cancer therapies in an environment that emphasizes personalized cancer care and an interdisciplinary and collaborative approach to treatment. NYU Cancer Institute’s vigorous translational research program is focused on discovering the origins of human cancer and to using that knowledge to eradicate the personal and societal burden of cancer. Through its seminars, cancer screenings, and other special programs for diverse populations, NYU Cancer Institute is also at the forefront of patient education in oncology and is working to ensure that highly advanced cancer care and education are available to all.

“From their special programs focused on molecularly-targeted therapies and signaling pathways in cancer, to their initiative to develop a personalized medicine laboratory that will map the molecular signatures of cancer, the NYU Cancer Institute is involved in some of the most exciting and promising cancer research in the world,” said Jack Lepping, president of the oncology division of Intellisphere, the publisher of OncLive. “This commitment to cutting-edge research and personalized cancer care make them an ideal partner for OncLive.”

This year, 20 cancer centers and nursing schools have joined OncLive’s Strategic Alliance Partnership program.

To learn more about OncLive^®, visit www.OncLive.com.

###

About OncLive^®

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive^® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research, and education. To learn more, please visit www.OncLive.com.

Media Contact:

Mike Gross

For OncLive

267-932-8760 Ext. 310 (Office)

mike@hornercom.com